Anteo Diagnostics to Acquire Established Global Diagnostics Company DIAsource ImmunoAssays SA

26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty

Continue
AACC Conference Summary and CEO Interview

Anteo Diagnostics Limited (ASX:ADO) (“Anteo” or the “Company”), released a copy of the presentation that Joshua Soldo delivered to a full house at the AACC OEM Lecture Series on Tuesday

Continue
Gearing Up For AACC: Anteo Extends Relationship with Sigma-Aldrich

Leading up to AACC, Anteo announced the distribution of their Mix&Go™ product range through Sigma-Aldrich. Mix&Go Reagents, Coupling and Activation Kits are expected to be available during Q3 of CY2015.

Continue
SCIENION and Anteo Partner to Develop Consumables for Better Functionality and Longer Shelf Life of Protein Microarrays

SCIENION, a leading global provider of ultra-low volume precision liquid handling systems, and Australian biotech company Anteo Technologies today announced that they have partnered to co-develop protein microarray consumables using

Continue
Anteo Begins InVivo Research Partnership with UQ

Today Anteo Technologies Pty Ltd (a subsidiary of Anteo Diagnostics Limited, ASX: ADO) is pleased to announce the launch of a research partnership with the Australian Institute for Bioengineering and

Continue